Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Aurora kinase B inhibitor

DRUG CLASS:

Aurora kinase B inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

No biomarker	Small Cell Lung Cancer	No biomarker	Small Cell Lung Cancer	CS 2164 Sensitive: B - Late Trials CS 2164 Sensitive : B	CS 2164 Sensitive: B - Late Trials CS 2164 Sensitive : B
BCL2 overexpression	Non Small Cell Lung Cancer	BCL2 overexpression	Non Small Cell Lung Cancer	AZD2811 Resistant: D – Preclinical AZD2811 Resistant : D	AZD2811 Resistant: D – Preclinical AZD2811 Resistant : D
BRAF V600E + PTEN deletion	Melanoma	BRAF V600E + PTEN deletion	Melanoma	HI-511 Sensitive: D – Preclinical HI-511 Sensitive : D	HI-511 Sensitive: D – Preclinical HI-511 Sensitive : D
CDH1 overexpression	Small Cell Lung Cancer	CDH1 overexpression	Small Cell Lung Cancer	AZD2811 Resistant: D – Preclinical AZD2811 Resistant : D	AZD2811 Resistant: D – Preclinical AZD2811 Resistant : D
MYC expression	Small Cell Lung Cancer	MYC expression	Small Cell Lung Cancer	AZD2811 Sensitive: D – Preclinical AZD2811 Sensitive : D	AZD2811 Sensitive: D – Preclinical AZD2811 Sensitive : D
VIM expression	Small Cell Lung Cancer	VIM expression	Small Cell Lung Cancer	AZD2811 Sensitive: D – Preclinical AZD2811 Sensitive : D	AZD2811 Sensitive: D – Preclinical AZD2811 Sensitive : D
POU2F3 expression	Small Cell Lung Cancer	POU2F3 expression	Small Cell Lung Cancer	AZD1152 Sensitive: D – Preclinical AZD1152 Sensitive : D	AZD1152 Sensitive: D – Preclinical AZD1152 Sensitive : D
KDELR3 overexpression	Uveal Melanoma	KDELR3 overexpression	Uveal Melanoma	NMI-900 Resistant: D – Preclinical NMI-900 Resistant : D	NMI-900 Resistant: D – Preclinical NMI-900 Resistant : D